SYMBOL
 
SurgiLight Logo SurgiLight, Inc. (OTCBB: SRGL)

SurgiLight, Inc. Article

CLINICAL OUTCOMES AND THEORY OF OPTIVISION™ LASER PRESBYOPIA REVERSAL
(LAPR)


V. Kadambi, M.D.
Sai Krupa Clinical of Laser Vision
Bangalor, India

INTRODUCTION
Presbyopia is a condition that effects the vast majority of middle-aged individuals. Conventionally, it is treated by the use of additional convex lens spectacles for near work and reading. In the last decade many attempts have been made to surgically reverse this condition. Two of the most common techniques, although neither are FDA cleared, are the Schachar technique, which involves the insertion of implants to expand the sclera, and the Thorton technique, which uses surgical incisions to expand the sclera.

Laser Presbyopia Reversal (LAPR) is being tested by clinical evaluators. The technique is still being evolved, but it may be described in brief as multiple four-quadrant ablative excisions over the sclera overlying the ciliary muscle. A prospective study to assess the safety, efficacy and stability of LAPR is underway at the Sai Krupa Clinic of Laser Vision, Bangalore, India.

MATERIALS AND METHODS
Six patients each had both eyes treated with the OptiVision™ Er:YAG Laser System
and fiber-optic delivery system manufactured by SurgiLight Inc., USA. In our study, the
patients were divided into two groups based on age. Group I was between 40-50 years while Group II was between 51-60 years. Subjects were selected with pre-operative refractive distance vision between +1.0 to +1.5 Diopters. The eyes were thoroughly screened to rule out pre-existing pathology. Pre-operative and follow-up examinations included
refraction, slit lamp
examination, fundoscopy, IOP measurements, keratometry, corneal topography and visual
field evaluation. Currently, the followup periods range from 2 weeks to 3 months.

The procedure was done under infiltration anesthesia using 2% Lidocaine with adrenaline.
Topical anesthesia was instilled just prior to infiltration. After making four fornix-based conjunctival flaps in the intermuscular region and achieving hemostasis with bipolar cautery, four pairs of radial ablative scleral excisions were made – one pair in each quadrant. The ength of each incision was approximately 4.5 mm starting 0.5 mm from the limbus. The separation between the paired incisions was approximately 2.5 mm. The depth of the grooves was about 75% of scleral thickness using the blue hue of choroid as the endpoint indicator. The peritomy sites were closed with bipolar forceps. The patient was prescribed topical antibiotics and teroids along with analgesic tablets. The patients’ eye was not patched and they were instructed to use their eyes normally for near and far vision within 24 hours postoperatively.

RESULTS
The mean pre-operative near add in Group I was 1.56 Diopters while in Group II was 2.25
Diopters. The near vision (tested at 35 cm reading distance) in Group I with full distance
correction was J2 to J4 and in Group II between J5 to J6. One week post-LAPR all subjects
read J1 without near addition. All patients reported mild discomfort for 24 to 48 hours post-operatively, including dry eyes. Conjunctival hyperemia lasted 2-4 weeks. The general observation was that subjective near visionimprovement was noticed within 2 days following the procedure. It continued to improve over 2-4 weeks, showing dramatic improvement after the fellow eye was treated. The time interval for treating the fellow eye varied from 0-4 weeks. No myopic shift and no regression were noted during the follow-up period (maximum 3 months). No significant change in refraction for distance was noticed. There was no induced astigmatism. There were some differences in the manner and speed of conjunctival healing. Specifically, the scleral scars were visible and quite noticeable in some cases, but there was tendency for this to decrease with time. No significant complications were encountered.

DISCUSSION
It is believed that accommodation results from the contraction of the ciliary muscle. As age dvances, there is a relative decrease in functional range of the ciliary muscle. Factors such as hardening of the lens, atrophy of the muscle, as well as “crowding of the muscle” have been attributed as causes for decreased accommodation. Thornton proposed reversal of presbyopia by anterior ciliary sclerotomy. He recognized that some of his RK patients, in whom the ncisions extended through the limbus in the sclera, had not developed presbyopia at the same time or in the same amount as his untreated patients. He hypothesized that the scleral incisions were responsible for this decrease in loss of accommodation. He organized several surgeons worldwide to study the results of the scleral incisions. Fukasaku carried out anterior iliary sclerotomy with the implantation of silicone expansion plug. Schachar achieved scleral expansion by insertion of implants. SurgiLight’s LAPR technique proposed by Dr. J.T. Lin
involves four pairs of symmetrical partial thickness radial incisions in the sclera over the ciliary body. This ablation of the scleral and resulting ingrowth of fibrous tissue, appears to improve the ciliary muscle function. Another hypothesis, the “Lin-Kadambi” theory, attributes the increased ciliary muscle functional range to increased elasticity of the scleral ring resulting
from the ablation. The absence of significant regression is due to a “fill-in” of the grooves by fibrin-like tissue. As a procedure, LAPR was found to be non skill-intensive with a short learning curve. Initially, the average surgical time was around 45 minutes. This has been
reduced to around 20 minutes per eye, while lasing time is a few seconds per incision. The OptiVision is an extremely reliable laser, since it employs solidstate technology. The energy output is very stable provided the surgeon ensures that proper contact tip technique is utilized. All cases demonstrated a significant subjective increase in accommodation.

Although the amount of presbyopic reversal is more or less the same in both age-groups, it is my belief that the net effect is more demonstrable in the younger age group. It is my feeling that patients above the age of fifty may not show uniform results due to the additional factor of lens hardening or scleral rigidity.

SUMMARY
Our initial clinical study demonstrates that LAPR procedure using the OptiVision Erbium:YAG Laser is an effective and safe method to surgically reverse presbyopia. Visual recovery is quick. Our patients are satisfied with the results. Long-term follow-up is necessary to evaluate stability of effect. Reference: Lin, JT, Kadambi, V, Mallo, O, Hwang, MY, Book Chapters in: Presbyopia: the Last Frontier, ed. by S. Agarwal et al. (2001), New York, SLAK..

SurgiLight, Inc. (OTCBB: SRGL)
12001 Science Drive, Suite 140, Orlando, FL 32826 • Tel. (407) 482-4555 • Fax (407) 482-0505 • Website www.surgilight.com • Email surgilightsales@aol.com
11-01

 



Disclaimer:
All material herein is information supplied by the company or other sources believed to be reliable. The information contained herein is not guaranteed by TheNewsGate.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this profile have approved the statements made in this profile. This profile contains forward-looking statements that involve risks and uncertainties. Statements in this press release about the company's future expectations, including: development of licensing and branding and all other statements in this release, other than historical facts, are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, section 21E of the Securities Act of 1934, as that term is defined in the Private Securities Reform Act of 1995. It is important to note that actual results and ultimate corporate actions could differ materially from those in such forward looking statements. Such "forward-looking statements" are subject to risks and uncertainties set forth from time to time in the Company's SEC reports. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. TheNewsGate.com is not a licensed broker, broker dealer, market marker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://TheNewsGate.com/ TheNewsGate.com's affiliates, officers, directors and employees may have bought or may buy the shares discussed in this profile and may profit in the event those shares rise in value. TheNewsGate.com does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

 
   
     
 
TheNewsGate.com Home Stock Profiles Penny Stock Education Advertise with TheNewsGate.com Financial Links